Great Point Partners LLC Ionis Pharmaceuticals Inc Transaction History
Great Point Partners LLC
- $216 Million
- Q3 2024
A detailed history of Great Point Partners LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Great Point Partners LLC holds 255,000 shares of IONS stock, worth $9.03 Million. This represents 4.72% of its overall portfolio holdings.
Number of Shares
255,000
Previous 330,000
22.73%
Holding current value
$9.03 Million
Previous $15.7 Million
35.05%
% of portfolio
4.72%
Previous 4.17%
Shares
7 transactions
Others Institutions Holding IONS
# of Institutions
402Shares Held
136MCall Options Held
862KPut Options Held
582K-
Vanguard Group Inc Valley Forge, PA15.1MShares$533 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD14.2MShares$502 Million0.34% of portfolio
-
Black Rock Inc. New York, NY10.3MShares$365 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA8.74MShares$309 Million0.06% of portfolio
-
Bellevue Group Ag Kuesnacht, V87.87MShares$279 Million5.32% of portfolio
About IONIS PHARMACEUTICALS INC
- Ticker IONS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 141,940,992
- Market Cap $5.02B
- Description
- Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...